These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11719669)

  • 41. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
    Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
    Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
    Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multinodular focal fatty infiltration of the liver: atypical imaging findings on delayed T1-weighted Gd-BOPTA-enhanced liver-specific MR images.
    Marin D; Iannaccone R; Catalano C; Passariello R
    J Magn Reson Imaging; 2006 Sep; 24(3):690-4. PubMed ID: 16878304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
    Filippone A; Blakeborough A; Breuer J; Grazioli L; Gschwend S; Hammerstingl R; Heinz-Peer G; Kittner T; Laghi A; Leen E; Lencioni R; Lucidarme O; Remplik P; Robinson PJ; Ruehm SG; Schaefer F; Stoupis C; Tombach B; Valette PJ; Zech CJ; Huppertz A
    J Magn Reson Imaging; 2010 Feb; 31(2):356-64. PubMed ID: 20099349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detectability of small liver metastases with gadolinium BOPTA.
    Runge VM; Lee C; Williams NM
    Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine.
    Knopp MV; Giesel FL; von Tengg-Kobligk H; Radeleff J; Requardt M; Kirchin MA; Hentrich HR
    J Magn Reson Imaging; 2003 Jun; 17(6):694-702. PubMed ID: 12766899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Visceral metastases from melanoma: findings on MR imaging.
    Premkumar A; Sanders L; Marincola F; Feuerstein I; Concepcion R; Schwartzentruber D
    AJR Am J Roentgenol; 1992 Feb; 158(2):293-8. PubMed ID: 1729784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Focal nodular hyperplasia of the liver: diffusion-weighted magnetic resonance imaging characteristics using high b values.
    Dohan A; Soyer P; Guerrache Y; Hoeffel C; Gavini JP; Kaci R; Boudiaf M
    J Comput Assist Tomogr; 2014; 38(1):96-104. PubMed ID: 24424559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
    Low RN; Sigeti JS
    AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metastasis versus focal eosinophilic infiltration of the liver in patients with extrahepatic abdominal cancer: an evaluation with gadobenate dimeglumine-enhanced magnetic resonance imaging.
    Park MS; Kim MJ; Lim JS; Kim SH; Kim HS; Chung YE; Kim KW
    J Comput Assist Tomogr; 2009; 33(1):119-24. PubMed ID: 19188798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gadobenate-dimeglumine-enhanced magnetic resonance imaging for hepatic lesions in children.
    Chavhan GB; Mann E; Kamath BM; Babyn PS
    Pediatr Radiol; 2014 Oct; 44(10):1266-74. PubMed ID: 24771094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The integrated diagnosis of hepatic focal nodular hyperplasia: echography, color Doppler, computed tomography and magnetic resonance compared].
    De Gaetano A; De Franco A; Maresca G; Manfredi R; Barbaro B; Monteforte MG
    Radiol Med; 1996 Mar; 91(3):258-69. PubMed ID: 8628940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions.
    Kim YK; Lee JM; Kim CS
    Eur Radiol; 2004 Jan; 14(1):5-13. PubMed ID: 14600778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
    Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A
    AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.
    Kim JI; Lee JM; Choi JY; Kim YK; Kim SH; Lee JY; Han JK; Choi BI
    Invest Radiol; 2008 Mar; 43(3):202-10. PubMed ID: 18301317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Focal nodular hyperplasia of the liver: diffusion and perfusion MRI characteristics.
    Donati F; Boraschi P; Gigoni R; Salemi S; Falaschi F; Bartolozzi C
    Magn Reson Imaging; 2013 Jan; 31(1):10-6. PubMed ID: 22898696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation.
    Pastor CM; Planchamp C; Pochon S; Lorusso V; Montet X; Mayer J; Terrier F; Vallee JP
    Radiology; 2003 Oct; 229(1):119-25. PubMed ID: 12944603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.